Bioequivalence and Bioavailability Forum

Subject	Category	Author	posted	Replies	last R.	Views
Test License Test License Test License	Regulatives / Guidelines	rajasekharkakarla	2018-10-06 08:05	2	2018-10-07 21:04	234
Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver Solubility based Biowaiver	Dissolution / BCS / IVIVC	Amalia	2018-10-01 11:04	10	2018-10-06 19:59	481
Retention of BA/BE samples	Regulatives / Guidelines	Neelu Singh	2018-10-05 06:57	0		208
Subject exclusion Subject exclusion Subject exclusion Subject exclusion Subject exclusion Subject exclusion Subject exclusion Subject exclusion Subject exclusion Subject exclusion Subject exclusion Subject exclusion	Outliers	Mohamed Yehia	2018-10-02 21:25	11	2018-10-03 23:47	593
FDA Recommendation on Matrix Effect Determination in CC Assay FDA Recommendation on Matrix Effect Determination in CC Assay FDA Recommendation on Matrix Effect Determination in CC Assay Reducing matrix effects	Bioanalytics	Obinoscopy	2018-10-01 14:38	3	2018-10-01 17:20	271
Kinetica is over Kinetica is over Kinetica is over Kinetica is over Kinetica is over Life style	Software	mittyri	2018-09-27 17:45	5	2018-09-28 16:08	704
RSABE - Sequence Suggested: TRT\|RTR Suggested: TRT\|RTR	RSABE / ABEL	Sundar.M	2018-09-27 11:11	2	2018-09-28 13:36	279
Error in bear Error in bear	R for BE/BA	tshianza	2018-09-28 08:16	1	2018-09-28 09:49	264
Spiramycine	Bioanalytics	giang nidqc	2018-09-27 08:55	0		161
LBAs Studies Forum policy	Bioanalytics	Dipal Patel	2018-09-25 14:33	1	2018-09-25 15:44	278
Pivotal study documentation for submission	Regulatives / Guidelines	Amalia	2018-09-24 14:22	0		261
Reference Scale Average Bioequivalence Approach: ANVISA, Brazil RSABE - ANVISA	Regulatives / Guidelines	Maitri	2018-09-21 19:49	1	2018-09-22 14:11	371
Sample size determination for in-vitro superiority study	Regulatives / Guidelines	sudy	2018-09-21 08:46	0		215
Usage of different lots of RLDs in multistage adaptive studies Usage of different lots of RLDs in multistage adaptive studies Usage of different lots of RLDs in multistage adaptive studies	Regulatives / Guidelines	manusyriac	2018-09-20 09:45	2	2018-09-20 13:05	320
Endogenous NTI drugs	Regulatives / Guidelines	NK	2018-09-19 07:31	0		288
Regulatory submissions T vs. R1 and T vs. R2 T vs. R1 and T vs. R2	Design Issues	rajasekharkakarla	2018-09-14 14:13	2	2018-09-17 06:57	549

Bioequivalence and Bioavailability Forum 11:08 CEST